IDEAYA Biosciences (IDYA) Other Non-Current Assets (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Other Non-Current Assets of $1.3 million for Q1 2026, up 59.13% on a YoY basis from $805000.0 in Q1 2025, and up 26.21% sequentially from $1.0 million in Q4 2025.
IDEAYA Biosciences (IDYA) Other Non-Current Assets (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 59.13% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 59.13% YoY), and the FY2025 full-year result was $1.0 million, up 26.09% from the prior year.
- Other Non-Current Assets rose to $1.3 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q1 2026 to a low of $106000.0 in Q1 2022.
- A 5-year average of $636823.5 and a median of $757000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 63.57% in 2022 and soared 614.15% in 2023, its largest moves.
- Tracing IDYA's Other Non-Current Assets over 5 years: stood at $106000.0 in 2022, then soared by 614.15% to $757000.0 in 2023, then rose by 6.34% to $805000.0 in 2024, then climbed by 26.09% to $1.0 million in 2025, then climbed by 26.21% to $1.3 million in 2026.
- Business Quant data shows IDYA's Other Non-Current Assets at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $805000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 805,000.00 |
| Jun 30, 2025 | 805,000.00 |
| Mar 31, 2025 | 805,000.00 |
| Dec 31, 2024 | 805,000.00 |
| Sep 30, 2024 | 911,000.00 |
| Jun 30, 2024 | 911,000.00 |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 757,000.00 |
| Sep 30, 2023 | 722,000.00 |
| Jun 30, 2023 | 722,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 106,000.00 |
| Dec 31, 2021 | 291,000.00 |
| Sep 30, 2021 | 217,000.00 |
| Jun 30, 2021 | 106,000.00 |